Salk researchers have discovered, for the first time, how to place DNA in specific locations in non-dividing cells
Salk Institute researchers have discovered a holy grail of gene editing—the ability to, for the first time, insert DNA at a target location into the non-dividing cells that make up the majority of adult organs and tissues. The technique, which the team showed was able to partially restore visual responses in blind rodents, will open new avenues for basic research and a variety of treatments, such as for retinal, heart and neurological diseases.
“We are very excited by the technology we discovered because it’s something that could not be done before,” says Juan Carlos Izpisua Belmonte, a professor in Salk’s Gene Expression Laboratory and senior author of the paper published on November 16, 2016 in Nature. “For the first time, we can enter into cells that do not divide and modify the DNA at will. The possible applications of this discovery are vast.”
Until now, techniques that modify DNA—such as the CRISPR-Cas9 system—have been most effective in dividing cells, such as those in skin or the gut, using the cells’ normal copying mechanisms. The new Salk technology is ten times more efficient than other methods at incorporating new DNA into cultures of dividing cells, making it a promising tool for both research and medicine. But, more importantly, the Salk technique represents the first time scientists have managed to insert a new gene into a precise DNA location in adult cells that no longer divide, such as those of the eye, brain, pancreas or heart, offering new possibilities for therapeutic applications in these cells.
To achieve this, the Salk researchers targeted a DNA-repair cellular pathway called NHEJ (for “non-homologous end-joining”), which repairs routine DNA breaks by rejoining the original strand ends. They paired this process with existing gene-editing technology to successfully place new DNA into a precise location in non-dividing cells.
“Using this NHEJ pathway to insert entirely new DNA is revolutionary for editing the genome in live adult organisms,” says Keiichiro Suzuki, a senior research associate in the Izpisua Belmonte lab and one of the paper’s lead authors. “No one has done this before.”
First, the Salk team worked on optimizing the NHEJ machinery for use with the CRISPR-Cas9 system, which allows DNA to be inserted at very precise locations within the genome. The team created a custom insertion package made up of a nucleic acid cocktail, which they call HITI, or homology-independent targeted integration. Then they used an inert virus to deliver HITI’s package of genetic instructions to neurons derived from human embryonic stem cells.
“That was the first indication that HITI might work in non-dividing cells,” says Jun Wu, staff scientist and co-lead author. With that feat under their belts, the team then successfully delivered the construct to the brains of adult mice. Finally, to explore the possibility of using HITI for gene-replacement therapy, the team tested the technique on a rat model for retinitis pigmentosa, an inherited retinal degeneration condition that causes blindness in humans. This time, the team used HITI to deliver to the eyes of 3-week-old rats a functional copy of Mertk, one of the genes that is damaged in retinitis pigmentosa. Analysis performed when the rats were 8 weeks old showed that the animals were able to respond to light, and passed several tests indicating healing in their retinal cells.
“We were able to improve the vision of these blind rats,” says co-lead author Reyna Hernandez-Benitez, a Salk research associate. “This early success suggests that this technology is very promising.”
The team’s next steps will be to improve the delivery efficiency of the HITI construct. As with all genome editing technologies, getting enough cells to incorporate the new DNA is a challenge. The beauty of HITI technology is that it is adaptable to any targeted genome engineering system, not just CRISPR-Cas9. Thus, as the safety and efficiency of these systems improve, so too will the usefulness of HITI.
“We now have a technology that allows us to modify the DNA of non-dividing cells, to fix broken genes in the brain, heart and liver,” says Izpisua Belmonte. “It allows us for the first time to be able to dream of curing diseases that we couldn’t before, which is exciting.”
The Latest on: Gene editing
[google_news title=”” keyword=”gene editing” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Gene editing
- Gene Silencing Slashes Cholesterol in Mice—No Gene Edits Requiredon February 29, 2024 at 1:26 pm
With a single shot of an epigenetic editor, the mice’s cholesterol levels rapidly dropped, and stayed low for nearly a year without notable side effects.
- Novel Gene Editing Tool Improves Immune Cell Activityon February 29, 2024 at 8:00 am
Jennifer Doudna and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in gene editing. The gene editing techn | Immunology ...
- Asia-Pacific Gene Editing Technology Research Report 2024on February 29, 2024 at 7:03 am
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Gene Editing Technologies Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering. The ...
- Why Cell And Gene Therapy Design Processes Need More Efficient Quality Controlson February 29, 2024 at 3:00 am
Drugmakers must make the entire drug testing and quality control process as efficient and innovative as the drug discovery method itself.
- The Fight to Pay for Gene Therapyon February 29, 2024 at 2:01 am
There is new hope for seemingly incurable diseases, but the treatments will be truly revolutionary only if they are available to everyone.
- ‘Bad’ cholesterol gene silenced without altering the DNA sequenceon February 28, 2024 at 11:30 pm
By silencing the gene responsible for regulating ‘bad’ cholesterol without altering the primary DNA sequence, researchers have shown that it’s possible to use epigenetic editing to treat diseases ...
- Ginkgo adds gene editing tools in buyout of Feng Zhang-founded startupon February 28, 2024 at 12:59 am
Ginkgo Bioworks has acquired a biotechnology startup co-founded by gene editing pioneer Feng Zhang, part of the cell engineering company’s plan to build up technologies that can help other companies ...
- Gene-Edited Pork Could Be Coming Soon to Your Dinner Plateon February 27, 2024 at 7:31 am
Scientists are using CRISPR technology to make pigs immune to a deadly virus—and they’re hoping for FDA approval by early next year Sarah Kuta Daily Correspondent Gene editing has produced a healthy ...
- Using CRISPR gene editing to prevent pigs from getting blue-ear pig diseaseon February 26, 2024 at 6:11 am
A team of bio-scientists affiliated with a host of institutions across the U.S. has developed a gene editing technique to produce newborn pigs immune to porcine reproductive and respiratory syndrome, ...
via Bing News